Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Proteome Sciences, Janssen sign research agreement
Under the agreement, PS Biomarker Services is expected to use a combination of its proprietary TMT isobaric mass tag technology, sample preparation and bioinformatics with Orbitrap Velos mass
Under the agreement, PS Biomarker Services is expected to use a combination of its proprietary TMT isobaric mass tag technology, sample preparation and bioinformatics with Orbitrap Velos mass
The VALOR trial is expected to recruit 450 evaluable patients at sites in the US, Canada, Europe, Australia and New Zealand. In the VALOR trial, the patients will
Pro-Pharmaceuticals said that in previous experiments its polysaccharide compounds that target Galectin receptors have been shown to reverse the formation of fibrotic tissue in diseased rat livers. Scott
MorphoSys’s clinical pipeline now comprises nine partnered programs in Phase 1 and five in Phase 2 development as well as the company’s proprietary programs MOR103, which is in
‘081 is a single molecule functioning as both a muscarinic antagonist and a beta2 receptor agonist (MABA). ‘081 is an investigational compound within the inhaled bifunctional muscarinic antagonist-beta2
Merrion claims that its patented drug delivery technology, GIPET, is supported by a large database reflecting 10 years’ research and development by drug delivery experts and 21 clinical
The company said that the new manufacturing unit is expected to be operational in 2015 and requires an investment of EUR250m in two steps. UCB Technical Operations &
Reportedly, the Drug Controller General of India (DCGI) office has directed the state regulatory bodies to begin inspections to take stock of the situation. Out of the 3000
The transaction is expected to provide DSM with new opportunities in the infant nutrition segment as well as food and beverage and dietary supplements. It will also provide
Paracetamol, also known as acetaminophen, is an over-the-counter (OTC) drug used to treat mild to moderate pain from headaches, backaches, osteoarthritis and to reduce fever. Genmed first filed